| Product Code: ETC13225200 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America CRISPR Gene-Editing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America CRISPR Gene-Editing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America CRISPR Gene-Editing Market Revenues & Volume, 2021 & 2031F |
3.3 North America CRISPR Gene-Editing Market - Industry Life Cycle |
3.4 North America CRISPR Gene-Editing Market - Porter's Five Forces |
3.5 North America CRISPR Gene-Editing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America CRISPR Gene-Editing Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
3.7 North America CRISPR Gene-Editing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 North America CRISPR Gene-Editing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 North America CRISPR Gene-Editing Market Revenues & Volume Share, By Services, 2021 & 2031F |
3.10 North America CRISPR Gene-Editing Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.11 North America CRISPR Gene-Editing Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 North America CRISPR Gene-Editing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America CRISPR Gene-Editing Market Trends |
6 North America CRISPR Gene-Editing Market, 2021 - 2031 |
6.1 North America CRISPR Gene-Editing Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America CRISPR Gene-Editing Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.1.3 North America CRISPR Gene-Editing Market, Revenues & Volume, By Autoimmune or Inflammatory, 2021 - 2031 |
6.2 North America CRISPR Gene-Editing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America CRISPR Gene-Editing Market, Revenues & Volume, By Genome Engineering, 2021 - 2031 |
6.2.3 North America CRISPR Gene-Editing Market, Revenues & Volume, By Disease Models, 2021 - 2031 |
6.2.4 North America CRISPR Gene-Editing Market, Revenues & Volume, By Functional Genomics, 2021 - 2031 |
6.2.5 North America CRISPR Gene-Editing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America CRISPR Gene-Editing Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America CRISPR Gene-Editing Market, Revenues & Volume, By CRISPR or Cas9, 2021 - 2031 |
6.3.3 North America CRISPR Gene-Editing Market, Revenues & Volume, By Zinc Finger Nucleases, 2021 - 2031 |
6.3.4 North America CRISPR Gene-Editing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America CRISPR Gene-Editing Market, Revenues & Volume, By Services, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America CRISPR Gene-Editing Market, Revenues & Volume, By Design Tools, 2021 - 2031 |
6.4.3 North America CRISPR Gene-Editing Market, Revenues & Volume, By Plasmid and Vector, 2021 - 2031 |
6.4.4 North America CRISPR Gene-Editing Market, Revenues & Volume, By Cas9 and g-RNA, 2021 - 2031 |
6.4.5 North America CRISPR Gene-Editing Market, Revenues & Volume, By Delivery System Products, 2021 - 2031 |
6.4.6 North America CRISPR Gene-Editing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 North America CRISPR Gene-Editing Market, Revenues & Volume, By Products, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America CRISPR Gene-Editing Market, Revenues & Volume, By GenCrispr or Cas9 kits, 2021 - 2031 |
6.5.3 North America CRISPR Gene-Editing Market, Revenues & Volume, By GenCrispr Cas9 Antibodies, 2021 - 2031 |
6.5.4 North America CRISPR Gene-Editing Market, Revenues & Volume, By GenCrispr Cas9 Enzymes, 2021 - 2031 |
6.5.5 North America CRISPR Gene-Editing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America CRISPR Gene-Editing Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America CRISPR Gene-Editing Market, Revenues & Volume, By Biotechnology and Pharmaceutical Companies, 2021 - 2031 |
6.6.3 North America CRISPR Gene-Editing Market, Revenues & Volume, By Academic and Government Research Institutes, 2021 - 2031 |
6.6.4 North America CRISPR Gene-Editing Market, Revenues & Volume, By Contract Research Organizations, 2021 - 2031 |
6.6.5 North America CRISPR Gene-Editing Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America CRISPR Gene-Editing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America CRISPR Gene-Editing Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.2.1 United States (US) CRISPR Gene-Editing Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.2.2 Canada CRISPR Gene-Editing Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.2.3 Rest of North America CRISPR Gene-Editing Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
7.3 North America CRISPR Gene-Editing Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United States (US) CRISPR Gene-Editing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Canada CRISPR Gene-Editing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 Rest of North America CRISPR Gene-Editing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 North America CRISPR Gene-Editing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.1 United States (US) CRISPR Gene-Editing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.2 Canada CRISPR Gene-Editing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.3 Rest of North America CRISPR Gene-Editing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5 North America CRISPR Gene-Editing Market, Revenues & Volume, By Services, 2021 - 2031 |
7.5.1 United States (US) CRISPR Gene-Editing Market, Revenues & Volume, By Services, 2021 - 2031 |
7.5.2 Canada CRISPR Gene-Editing Market, Revenues & Volume, By Services, 2021 - 2031 |
7.5.3 Rest of North America CRISPR Gene-Editing Market, Revenues & Volume, By Services, 2021 - 2031 |
7.6 North America CRISPR Gene-Editing Market, Revenues & Volume, By Products, 2021 - 2031 |
7.6.1 United States (US) CRISPR Gene-Editing Market, Revenues & Volume, By Products, 2021 - 2031 |
7.6.2 Canada CRISPR Gene-Editing Market, Revenues & Volume, By Products, 2021 - 2031 |
7.6.3 Rest of North America CRISPR Gene-Editing Market, Revenues & Volume, By Products, 2021 - 2031 |
7.7 North America CRISPR Gene-Editing Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7.1 United States (US) CRISPR Gene-Editing Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7.2 Canada CRISPR Gene-Editing Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7.3 Rest of North America CRISPR Gene-Editing Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8 North America CRISPR Gene-Editing Market Key Performance Indicators |
9 North America CRISPR Gene-Editing Market - Export/Import By Countries Assessment |
10 North America CRISPR Gene-Editing Market - Opportunity Assessment |
10.1 North America CRISPR Gene-Editing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America CRISPR Gene-Editing Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
10.3 North America CRISPR Gene-Editing Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 North America CRISPR Gene-Editing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.5 North America CRISPR Gene-Editing Market Opportunity Assessment, By Services, 2021 & 2031F |
10.6 North America CRISPR Gene-Editing Market Opportunity Assessment, By Products, 2021 & 2031F |
10.7 North America CRISPR Gene-Editing Market Opportunity Assessment, By End-Users, 2021 & 2031F |
11 North America CRISPR Gene-Editing Market - Competitive Landscape |
11.1 North America CRISPR Gene-Editing Market Revenue Share, By Companies, 2022 |
11.2 North America CRISPR Gene-Editing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here